Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Smart Technology Integration Is Expected To Revolutionize The Outdoor Kitchen…
The Smart Revolution The Smart Revolution A transformative trend within theoutdoor kitchen appliances marketis the integration of smart and connected technology. Companies in the outdoor kitchen appliances market are increasingly focusing on developing appliances that are compatible with IoT (Internet of Things), Wi-Fi, and other technologies. These innovations empower users to control and monitor their outdoor kitchen appliances remotely via smartphones or voice commands,...
PR Newswire
12/09/2023
Transactions in connection with share buy-back program
Company announcement no. 47 - 2312 September 2023 Transactions in connection with share buy-back program On 3 August 2023 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company announcement no. 38 - 23. The program will be executed in accordance with the principles of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbor rules...
Nasdaq GlobeNewswire
12/09/2023
Clinical Decision Support Systems (CDSS) Market worth $2.5 billion |…
Clinical Decision Support Systems (CDSS) Market in terms of revenue was estimated to be worth $1.7 billion in 2023 and is poised to reach $2.5 billion by 2028, growing at a CAGR of 7.5% from 2023 to 2028 according to a new report by MarketsandMarkets™. Clinical Decision Support Systems (CDSS) Market in terms of revenue was estimated to be worth$1.7 billionin 2023 and is poised to reach$2.5 billionby 2028, growing at a CAGR of 7.5% from 2023 to 2028 according to a new report by...
PR Newswire
12/09/2023
The Conjugation and Labeling Services Market is projected to grow at a CAGR of…
A number of drug developers and research institutes currently lack the technical expertise related to bioconjugation chemistries, along with limited in-house capabilities and scarcity of advanced bioconjugation technologies, which are essential to carry out the process of conjugation. In order to leverage the relevant experience and expertise of service providers, several organizations prefer to outsource their antibody conjugation services and protein labeling operations. Additionally, various…
PR Newswire
12/09/2023
The Bioavailability Enhancement Services Market is projected to grow at an…
Bioavailability is known to form an integral part of the drug pharmacokinetics. As a result, over the last couple of years, the concept of bioavailability has garnered significant attention in the pharmaceutical industry. Further, a study conducted on terminated drug development projects revealed that majority of the candidates fail in early phases. The study further highlighted that the aforementioned drug failures can primarily be attributed to the problems associated with pharmacokinetic…
PR Newswire
12/09/2023
Industrial Hemp Market size worth USD 23.20 Billion, Globally, by 2030 at 14.05%…
Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=117111 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=117111 Browse in-depth TOCon" Industrial Hemp Market " 202 - Pages 126 – Tables 37 – Figures Global Industrial Hemp Market: Growing Demand and Regulatory Shifts Shape Industry Landscape The global Industrial Hemp Market is poised for significant expansion, driven by an array of market drivers...
PR Newswire
12/09/2023
Physiotherapy Equipment Market to Reach $2,795.10 Million by 2032, exhibiting a…
Physiotherapy equipment is used for the treatment of a range of disorders, injuries, and diseases. Electrotherapy equipment, ultrasound equipment, heat therapy equipment, cold therapy equipment, compression therapy equipment, and exercise therapy equipment are some of the physiotherapy equipment. Physiotherapy equipment is used for the treatment of a range of disorders, injuries, and diseases. Electrotherapy equipment, ultrasound equipment, heat therapy equipment, cold therapy equipment,...
PR Newswire
12/09/2023
Northwest Biotherapeutics Announces That Dr. Linda Liau Has Joined The Company's…
The longstanding members of the Company's Scientific Advisory Board include Dr. Samir Khleif, Dr. Jerome Galon and Dr. John Smyth, and also included Dr. Mac Cheever for many years until his passing. The longstanding members of the Company's Scientific Advisory Board include Dr.Samir Khleif, Dr.Jerome Galonand Dr.John Smyth, and also included Dr.Mac Cheeverfor many years until his passing. Linda Powers, NWBio CEO, commented: "We are delighted to have Dr. Liau join our...
PR Newswire
12/09/2023
Image-Guided Radiation Therapy Market worth $2.4 billion | MarketsandMarkets
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171554723 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171554723 Browse in-depth TOC on "Image-Guided Radiation Therapy Market" 120 - Tables 40 - Figures 200 - Pages Image-Guided Radiation Therapy Market Scope: PET/ MRI-guided radiation therapy segment to register a significant growth rate over the forecast period of 2022-2028...
PR Newswire
12/09/2023
Frost & Sullivan Recognizes Suki AI with the 2023 North American Technology…
Each year, Frost & Sullivan presents this award to the company that has developed a product with innovative features and functionality that is gaining rapid acceptance in the market. The award recognizes the quality of the solution and the customer value enhancements it enables. Each year, Frost & Sullivan presents this award to the company that has developed a product with innovative features and functionality that is gaining rapid acceptance in the market. The award recognizes the…
PR Newswire
12/09/2023
Aridhia and Replica Analytics partner on next-generation data sharing and…
With this new next-generation solution, set-up of collaborative analytics environments internally or for cross-company and international consortia is simplified. Data custodians have more granular control over how their data is accessed, generated, analyzed, and shared, as well as confidence in the privacy and security of the data. With fewer barriers to collaborating, they can extract valuable insights faster, ultimately enhancing decision-making and research outcomes. With this new...
PR Newswire
12/09/2023
Evolution Optiks Launches Clinical Study of Neuro-Optical Testing Device
"Our DeCon unit, which is intended to be marketed under our brand name NeuroDynamiks™, relies on proprietary technology that allows for tracking and analysis of involuntary movements of the eyeball in response to stimuli within the head-mounted device. These data are simultaneously recorded on the device and, if required, can be made available remotely for interpretation by a qualified medical practitioner", says Raul Mihali, President and Chief Executive Officer of Evolution Optiks…
PR Newswire
12/09/2023
TMRW Life Sciences Receives CE Mark for the CryoRobot Select, its…
The CRS modernizes a critical aspect of the IVF lab – the management and storage of frozen eggs and embryos. The CRS is an automated platform that combines proprietary, state-of-the-art hardware and software to safely track, monitor and store frozen eggs and embryos. The TMRW platform reduces potential points of failure by 94% compared to manual specimen management and storage systems, and it helps fertility clinics safely scale to meet growing patient demand by helping reduce the risk of…
PR Newswire
12/09/2023
LIMINAL BIOSCIENCES FILES AMENDED SCHEDULE 13E-3 AND SUPPLEMENT TO THE…
No changes have been made to the terms or conditions of the Arrangement, or the date of the special meeting of the Company's shareholders called to vote on the Arrangement. No changes have been made to the terms or conditions of the Arrangement, or the date of the special meeting of the Company's shareholders called to vote on the Arrangement. To date, approximately 71% of the votes have been received, of which a substantial majority of such votes are in favour of the Arrangement....
PR Newswire
12/09/2023
CSafe Expands Executive Team with Chief Financial Officer
Mr. Pishotti brings over 20 years of deep operating, financial, and commercial leadership across the Warehouse Automation, Material Handling, Aircraft Engines, Rail, and Energy industries. He rose through the finance teams at multiple high performing organizations, serving in CFO positions with Honeywell, GE Aviation, and GE Transportation. A true cross-functional executive, he was most recently the VP of Global Sales at Honeywell International. In this role he was responsible for a $2 billion…
PR Newswire
12/09/2023
Pierre Fabre Laboratories Acquires Vertical Bio and its Innovative Targeted…
This acquisition enables Pierre Fabre Laboratories to further strengthen their R&D portfolio in precision oncology with a product about to enter clinical development. In line with its innovation strategy, the Group has made oncology its top priority in medical care and dedicates every year circa 80% of its R&D spendings to this therapeutic area. In 2022, the Oncology Franchise achieved revenues of 467 M€, a sharp 221% increase vs 2019 revenues. This acquisition enables Pierre Fabre...
PR Newswire
12/09/2023
Dewpoint Therapeutics Partners with Chemify to Apply Groundbreaking Chemistry AI…
Under the partnership, Chemify will design and deliver novel compounds to augment Dewpoint's advanced oncology and neurodegeneration pipeline. Dewpoint may choose to exercise an option to acquire the compounds designed by Chemify. In exchange, Chemify will receive pre-negotiated, success-driven clinical and regulatory milestones and tiered royalties. Under the partnership, Chemify will design and deliver novel compounds to augment Dewpoint's advanced oncology and neurodegeneration pipeline...
PR Newswire
12/09/2023
Metabolon Launches New Biological Stress Discovery Panel to Aid Detection of…
Part of the Metabolon Discover portfolio of metabolomics services, the Biological Stress Discovery Panel encompasses 114 metabolites strongly associated with chronic stress and provides insights into various biological stress pathways, including inflammation, injury, circulation, and oxidative stress. The panel also examines other signaling molecules and signatures that can determine an individual's capacity to address stress and identify the presence and activity of specific stressors. Part...
PR Newswire
12/09/2023
Jazz Pharmaceuticals Announces Key Update to Leadership Team
Ms. Galá joined Jazz as CFO in March 2020, and brings more than two decades of broad experience across a range of life science companies including GRAIL, Theravance Biopharma and Eli Lilly and Company where she assumed progressive leadership responsibility through key areas spanning finance, strategy, corporate development, and commercial. Renee currently serves on the Board of Directors of Gossamer Bio, where she also chairs the audit committee, and previously served on the Board of Directors…
PR Newswire
12/09/2023
FONDAZIONE TELETHON AND ORCHARD THERAPEUTICS COMPLETE TRANSFER OF MARKETING…
MILAN, BOSTON, and LONDON, Sept. 12, 2023 /PRNewswire/ -- Fondazione Telethon, one of the main Italian biomedical charities, and Orchard Therapeutics, a global gene therapy leader, today announced the completion of the transfer of the marketing authorization for Strimvelis, a gene therapy approved by the European Medicines Agency in 2016 for the treatment of adenosine deaminase severe combined immunodeficiency (ADA-SCID). MILAN,BOSTON, andLONDON,Sept. 12, 2023/PRNewswire/ --...
PR Newswire
12/09/2023
e.l.f. Cosmetics Invites the UK to "express your e.l.f." in its Biggest…
Adding a special beat, e.l.f. teamed up with Caity Baser, one of the fastest emerging UK singer/ songwriters whose no-filter, catchy anthems have generated a loyal community following. Caity's larger-than-life personality aligns with e.l.f.'s personality of being a bold disruptor with a kind heart. Caity's upbeat new single "Disco Shoes" is the soundtrack for #expressyourelf. Adding a special beat, e.l.f. teamed up withCaity Baser, one of the fastest emerging UK singer/ songwriters…
PR Newswire
12/09/2023
Coloplast A/S - Financial Calendar 2023-24
Please see enclosed pdf.For more information and calendar invitations for upcoming events, please visit: https://investor.coloplast.com/investor-relations/financial-calendar-and-events/ Kind regards, Investor Relations Coloplast A/S Tel. +45 4911 1800 For further information, please contactInvestors and analysts Anders Lonning-Skovgaard Executive Vice President, CFO Tel. +45 4911 1111Aleksandra Dimovska Senior Director, Investor Relations Tel. +45 4911 1800 / +45 4911 2458...
Nasdaq GlobeNewswire
12/09/2023
AGS Therapeutics Named among Business Worldwide Magazines 20 Most Innovative…
AGS Therapeutics has emerged as a trailblazer in the rapidly evolving landscape of medical biotechnology, harnessing the untapped potential of Microalgae Extracellular Vesicles (MEVs) to revolutionise both, the delivery of biological drugs (such as mRNA and others), and the delivery of non-viral gene therapies, and to transform healthcare. AGS Therapeutics has emerged as a trailblazer in the rapidly evolving landscape of medical biotechnology, harnessing the untapped potential of Microalgae...
PR Newswire
12/09/2023
Relu® reaches medical quality standards with ISO13485 certification
"This certification demonstrates our commitment to international quality and regulatory standards. Relu wants to build AI that people can trust." says Holger Willems, Co-Founder & CEO at Relu. "This certification demonstrates our commitment to international quality and regulatory standards. Relu wants to build AI that people can trust." saysHolger Willems, Co-Founder & CEO at Relu. "We've achieved ISO13485, underscoring our commitment to quality and safety. This…
PR Newswire
12/09/2023
Altri Comunicati